| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 22, 2024 | RMD Resmed Inc | Leong Justin | Chief Product Officer | Sell | 6,160 | $243.09 | $1,497,415.92 | -22.1% | -4.5% | +2.9% | |
| Nov 22, 2024 | LFWD Lifeward Ltd. | Swinford Michael | Director | Buy | 16,907 | $1.83 | $30,899.23 | +63.8% | -3.7% | -72.6% | |
| Nov 22, 2024 | Lemaitre Dan | Director | Sell | 14,375 | $85.00 | $1,221,893.21 | -100% | -0.7% | +1.5% | ||
| Nov 22, 2024 | Davidar David D54 | Director | Sell | 40,000 | $85.00 | $3,400,049.99 | -2.8% | -0.7% | +1.5% | ||
| Nov 21, 2024 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 24,246 | $139.67 | $3,386,438.82 | -14.8% | +6.3% | +14.6% | |
| Nov 21, 2024 | MODD Modular Medical, Inc. | Manchester Management Co LLC | Chief Executive Officer | Buy | 166,666 | $1.50 | $249,999.00 | +5.3% | -42.8% | -77.1% | |
| Nov 21, 2024 | Scavilla Daniel T55 | President, CEO | Sell | 130,000 | $85.00 | $11,050,000.00 | -100% | -1.0% | +1.3% | ||
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | Encrantz Staffan74 | Director, 10% Owner | Sell | 551,802 | $3.73 | $2,058,221.46 | -46.6% | -26.1% | +93.1% | |
| Nov 21, 2024 | SGHT Sight Sciences, Inc. | Encrantz Staffan74 | Director, 10% Owner | Buy | 551,802 | $3.73 | $2,058,221.46 | +13.7% | -26.1% | +93.1% | |
| Nov 21, 2024 | BSX Boston Scientific Corp | Ludwig Edward J60 | Director | Sell | 4,877 | $91.63 | $446,901.94 | -11.0% | +15.5% | +5.9% | |
| Nov 21, 2024 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 100,000 | $10.06 | $1,006,000.00 | -0.9% | +6.4% | +98.9% | |
| Nov 21, 2024 | TNDM Tandem Diabetes Care Inc | Blickenstaff Kim D61 | Director | Sell | 40,000 | $31.04 | $1,241,400.00 | -10.0% | +3.2% | -30.8% | |
| Nov 21, 2024 | TLSI Trisalus Life Sciences, Inc. | Wahlstrom Mats58 | Director, 10% Owner | Buy | 10,727 | $4.39 | $47,056.68 | +525.8% | +29.1% | +14.4% | |
| Nov 20, 2024 | RBOT Vicarious Surgical Inc. | Sachs Adam David84 | CEO | Sell | 817 | $8.97 | $7,327.75 | -1.5% | +73.9% | -71.4% | |
| Nov 20, 2024 | PEN Penumbra Inc | Elsesser Adam62 | CEO And President | Sell | 15,000 | $237.28 | $3,559,175.51 | -0.4% | +13.4% | +17.0% | |
| Nov 20, 2024 | POCI Precision Optics Corporation, Inc. | Anania Peter V. | Director | Sell | 14,400 | $5.00 | $72,000.00 | -6.8% | -10.8% | -15.0% | |
| Nov 20, 2024 | NXGL Nexgel, Inc. | Drapczuk Adam E III62 | Chief Financial Officer | Buy | 17,500 | $2.75 | $48,125.00 | +30.5% | +9.7% | -50.9% | |
| Nov 20, 2024 | COCH Envoy Medical, Inc. | Patel Mona Chetan | Director | Buy | 2,500 | $2.28 | $5,698.75 | +50.0% | -33.0% | -67.6% | |
| Nov 20, 2024 | RBOT Vicarious Surgical Inc. | Kelly William John85 | CFO And Treasurer | Sell | 109 | $8.96 | $976.24 | -0.9% | +73.9% | -71.4% | |
| Nov 20, 2024 | NXGL Nexgel, Inc. | Henry Scott Robert72 | Director | Buy | 1,818 | $2.75 | $4,999.50 | +1.2% | +9.7% | -50.9% | |
| Nov 20, 2024 | DXCM Dexcom Inc | Stern Sadie72 | EVP, Chief Hr Officer | Sell | 4,259 | $74.73 | $318,275.07 | -5.6% | +20.3% | -22.4% | |
| Nov 20, 2024 | PRCT Procept Biorobotics Corp | Zadno Reza73 | President, CEO | Sell | 26,420 | $92.57 | $2,445,723.66 | -4.0% | -27.8% | -69.9% | |
| Nov 20, 2024 | RBOT Vicarious Surgical Inc. | Khalifa Sammy84 | Chief Technology Officer | Sell | 653 | $8.97 | $5,855.78 | -1.7% | +73.9% | -71.4% | |
| Nov 20, 2024 | LFWD Lifeward Ltd. | Swinford Michael | Director | Buy | 16,471 | $1.84 | $30,230.87 | +164.1% | +8.1% | -71.9% | |
| Nov 20, 2024 | NXGL Nexgel, Inc. | Zeldis Jerome B | Director | Buy | 3,636 | $2.75 | $9,999.00 | +3.5% | +9.7% | -50.9% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.